Collegium Pharmaceutical Inc (COLL)
Healthcare
Drug Manufacturers - Specialty & Generic
35.40 $
-1.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Collegium Pharmaceutical Inc (COLL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 98.8% of the shares are freely tradable; institutional investors hold 127.9%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
127.9%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
1.2%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
98.8%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
19.6%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
32Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 15.84 | 5,134,027 | +0.7 | 03/31/2026 |
| Vanguard Group Inc | 6.96 | 2,256,254 | +1.3 | 12/31/2025 |
| HHG PLC | 5.63 | 1,825,651 | +26.0 | 03/31/2026 |
| Amvescap Plc. | 4.91 | 1,591,909 | +35.5 | 03/31/2026 |
| Fuller & Thaler Asset Management Inc | 4.63 | 1,499,584 | -50.0 | 03/31/2026 |
| Renaissance Technologies Corp | 4.53 | 1,469,449 | -9.1 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 5.91 | 1,915,734 | +0.0 | 05/29/2026 |
| FullerThaler Beh Small-Cap Equity SMA | 4.41 | 1,430,708 | +0.0 | 12/31/2025 |
| FullerThaler Behavioral Sm-Cp Eq R6 | 4.41 | 1,430,708 | +0.0 | 04/30/2026 |
| FullerThaler Behavioral Small-Cap Equity | 4.41 | 1,430,708 | +0.0 | 12/31/2025 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.